Clinical Trial Update: Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic and pharmacodynamic study evaluating a fluticasone propionate and salmeterol combination delivered via capsule-based inhaler and multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-05-23